Omega-3 Polyunsaturated Fatty Acids and Cardiovascular Diseases

Journal of the American College of Cardiology

Volumn 54, Issue 7, 2009, Pages 585-594

  Lavie, Carl J ^a   Milani, Richard V ^a   Mehra, Mandeep R ^b   Ventura, Hector O ^a  

^a OCHSNER MEDICAL CENTER   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

3 polyunsaturated fatty acids; cardiovascular diseases; fish oils

Indexed keywords

ACETYLSALICYLIC ACID; ADIPONECTIN; ALDOSTERONE RECEPTOR BLOCKER; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; ARACHIDONIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; COLLAGEN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOCOSAHEXAENOIC ACID; DOCOSAHEXAENOIC ACID PLUS EICOSAPENTAENOIC ACID; FIBRIC ACID DERIVATIVE; FISH OIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ICOSAPENTAENOIC ACID; LINOLEIC ACID; NICOTINIC ACID; OLEIC ACID; OMEGA 3 FATTY ACID; PALMITIC ACID; RECEPTOR BLOCKING AGENT; ROSUVASTATIN; STEARIC ACID; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; WARFARIN;

ACUTE HEART INFARCTION; ANGINA PECTORIS; ANTIARRHYTHMIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ATHEROSCLEROSIS; AUTONOMIC NERVOUS SYSTEM; BLEEDING; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DRUG INDUCED DISEASE; ENDOTHELIUM; FISHY BURP; GASTROINTESTINAL SYMPTOM; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HEART PROTECTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; ISCHEMIC HEART DISEASE; MORTALITY; MYOCARDIAL DISEASE; NAUSEA; OPTIMAL DRUG DOSE; PRIMARY PREVENTION; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RETROSPECTIVE STUDY; REVIEW; SECONDARY PREVENTION; SUDDEN DEATH; THROMBOCYTE AGGREGATION; VASODILATATION;

ANIMALS; ARRHYTHMIAS, CARDIAC; ATHEROSCLEROSIS; CARDIOMYOPATHIES; CARDIOVASCULAR DISEASES; CORONARY DISEASE; DIET; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FATTY ACIDS, OMEGA-3; FISH OILS; FISHES; HEART CONDUCTION SYSTEM; HEART FAILURE; HUMANS; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEAFOOD; SECONDARY PREVENTION;

EID: 67849129098     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.02.084     Document Type: Review

References (90)

1. Rogans J.A. More on fish oil. N Engl J Med 316 (1987) 624-628
2. Lavie C.J., and Milani R.V. Fish oils. In: Messerli F.H. (Ed). Cardiovascular Drug Therapy (1996), Saunders, Philadelphia 1608-1613
3. Lee J.H., O'Keefe J.H., Lavie C.J., Marchioli R., and Harris W.S. Omega-3 fatty acids for cardioprotection. Mayo Clin Proc 83 (2008) 324-332
4. Kromhout D., Bosschieter E.B., and de Lezenne Coulander C. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 312 (1985) 1205-1209
5. Albert C.M., Hennekens C.H., O'Donnell C.J., et al. Fish consumption and risk of sudden cardiac death. JAMA 279 (1998) 23-28
6. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico [errata in Lancet 2001;357:642 and Lancet 2007;369:106]. Lancet 354 (1999) 447-455
7. Yokoyama M., Origasa H., Matsuzaki M., et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis [published correction appears in Lancet 2007;370:220]. Lancet 369 (2007) 1090-1098
8. GISSI-HF Investigators. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 372 (2008) 1223-1230
9. Kris-Etherton P.M., Harris W.S., Appel L.J., and American Heart Association Nutrition Committee. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease [published correction appears in Circulation 2003;107:512]. Circulation 106 (2002) 2747-2757
10. Sinclair H.M. The diet of Canadian Indians and Eskimos. Proc Nutr Soc 12 (1953) 69-82
11. Bang H.O., and Dyerberg J. Plasma lipids and lipoproteins in Greenlandic west coast Eskimos. Acta Med Scand 192 (1972) 85-94
12. Bang H.O., and Dyerberg J. Lipid metabolism and ischemic heart disease in Greenland Eskimos. Adv Nutr Res 3 (1980) 1-22
13. Dyerberg J., Bang H.O., and Hjorne N. Fatty acid composition of the plasma lipids in Greenland Eskimos. Am J Clin Nutr 28 (1975) 958-966
14. William H. Omega-3 fatty acids: the "Japanese" factor?. J Am Coll Cardiol 52 (2008) 425-427
15. Harris W.S., Poston W.C., and Haddock C.K. Tissue n-3 and n-6 fatty acids and risk for coronary heart disease events. Atherosclerosis 193 (2007) 1-10
16. Burr M.L., Fehily A.M., Gilbert J.F., et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: Diet And Reinfarction Trial (DART). Lancet 2 (1989) 757-761
17. Macchia A., Levantesi G., Franzosi M.G., et al. Left ventricular systolic dysfunction, total mortality, and sudden death in patients with myocardial infarction treated with n-3 polyunsaturated fatty acids. Eur J Heart Fail 7 (2005) 904-909
18. Marchioli R., Barzi F., Bomba E., et al., for the GISSI-Prevenzione Investigators. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 105 (2002) 1897-1903
19. Burr M.L., Ashfield-Watt P.A., Dunstan F.D., et al. Lack of benefit of dietary advice to men with angina: results of a controlled trial. Eur J Clin Nutr 57 (2003) 193-200
20. von Schacky C., and Harris W.S. Cardiovascular benefits of omega-3 fatty acids. Cardiovasc Res 73 (2007) 310-315
21. Nilsen D.W., Albrektsen G., Landmark K., Moen S., Aarsland T., and Woie L. Effects of a high-dose concentrate of n-3 fatty acids or corn oil introduced early after an acute myocardial infarction on serum triacylglycerol and HDL cholesterol. Am J Clin Nutr 74 (2001) 50-56
22. Senges S., and OMEGA Study Group. Randomized trial of omega-3 fatty acids on top of modern therapy after acute myocardial infarction: the OMEGA trial. Oral presentation at: Annual Scientific Sessions of the American College of Cardiology (March 2009) Orlando, FL
23. Plourde M., and Cunnane S.C. Extremely limited synthesis of long chain polyunsaturates in adults: implications for their dietary essentiality and use as supplements. Appl Physiol Nutr Metab 32 (2007) 619-634
24. Wang C., Harris W.S., Chung M., et al. n-3 fatty acid from fish or fish-oil supplements, but not [alpha]-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Am J Clin Nutr 84 (2006) 5-17
25. Campos H., Baylin A., and Wilett W.C. α-linolenic acid and risk of nonfatal acute myocardial infarction. Circulation 118 (2008) 339-345
26. Seikikawa A., Ueshima H., Kadowaki T., et al. Less subclinical atherosclerosis in Japanese men in Japan than in white men in the United States in the post-World War II birth cohort. Am J Epidemiol 165 (2007) 617-624
27. Seikikawa A., Curb J.D., and Ueshima H. Marine-derived n-3 fatty acids and atherosclerosis in Japanese, Japanese-American, and white men: a cross-sectional study. J Am Coll Cardiol 52 (2008) 417-424
28. Anand R.G., Alkadri M., Lavie C.J., and Milani R.V. The role of fish oil in arrhythmia prevention. J Cardiopulm Rehabil 28 (2008) 92-98
29. Reiffel J.A., and McDonald A. Antiarrhythmic effects of omega-3 fatty acids. Am J Cardiol 98 (2006) 501-601
30. Christensen J.H., Gustenhoff P., Korup E., et al. Effect of fish oil on heart rate viability in survivors of myocardial infarction: a double blind randomized controlled trial. Br Med J 312 (1996) 677-678
31. O'Keefe Jr. J.H., Abuissa H., Sastre A., Steinhaus D.M., and Harris W.S. Effects of omega-3 fatty acids on resting heart rate, heart rate recovery after exercise, and heart rate viability in men with healed myocardial infarctions and depressed ejection fractions. Am J Cardiol 97 (2006) 1127-1130
32. Geelen A., Brouwer I.A., Schouten E.G., Maan A.C., Katan M.B., and Zock P.I. Effects of n-3 fatty acids from fish on premature ventricular complexes and heart rate in humans. Am J Clin Nutr 81 (2005) 416-420
33. Mozaffarian D., Prineas R.J., Stein P.K., and Siscovick D.S. Dietary fish and n-3 fatty acid intake and cardiac electrocardiographic parameters in humans. J Am Coll Cardiol 48 (2006) 478-484
34. Raitt M.H., Connor W.E., Morris C., et al. Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trial. JAMA 293 (2005) 2884-2891
35. Leaf A., Albert C.M., Josephson M., et al. Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake. Circulation 112 (2005) 2762-2768
36. Brouwer I.A., Zock P.L., Camm A.J., et al. Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverter defibrillators: the Study on Omega-3 Fatty Acids and Ventricular Arrhythmia (SOFA) randomized trial. JAMA 295 (2006) 2613-2619
37. Mozaffarian D., Psaty B.M., Rimm E.B., et al. Fish intake and risk of incident atrial fibrillation. Circulation 110 (2004) 368-373
38. Brouwer I.A., Heeringa J., Geleijnse J.M., Zock P.L., and Witteman J.C. Intake of very long-chain n-3 fatty acids from fish and incidence of atrial fibrillation. The Rotterdam Study. Am Heart J 151 (2006) 857-862
39. Calo L., Bianconi L., Colicicchi F., et al. N-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial. J Am Coll Cardiol 45 (2005) 1723-1728
40. Crystal E., Garfinkle M.S., Conolly S.S., Ginger T.T., Sleik K., and Yusuf S.S. Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery. Cochrane Database Syst Rev 4 (2004) CD003611
41. Mozaffarian D., Bryson C.L., Lemaitre R.N., Burke G.L., and Siscovick D.S. Fish intake and risk of incident heart failure. J Am Coll Cardiol 45 (2005) 2015-2021
42. Yamagishi K., Nettleton J.A., and Folsom A.R. Plasma fatty acid composition and incident heart failure in middle-aged adults: the Atherosclerosis Risk In Communities (ARIC) study. Am Heart J 156 (2008) 965-974
43. Yamagishi K., Iso H., Date C., et al. Fish, omega-3 polyunsaturated fatty acids, and mortality from cardiovascular diseases in a nationwide community-based cohort of Japanese men and women. J Am Coll Cardiol 52 (2008) 988-996
44. Kliewer S.A., Sundseth S.S., Jones S.A., et al. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferators-activated receptors alpha and gamma. Proc Natl Acad Sci U S A 94 (1997) 4318-4323
45. Xu H.E., Lambert M.H., Montana V.G., et al. Molecular recognition of fatty acids by peroxisome proliferators-activated receptors. Mol Cell 3 (1999) 397-403
46. Stanley W.C., Recchia F.A., and Lopaschuk G.D. Myocardial substrate metabolism in the normal and failing heart. Physiol Rev 85 (2005) 1093-1129
47. Duda M.K., O'Shea K.M., Lei B., et al. Dietary supplementation with omega-3 PUFA increases adiponectin and attenuates ventricular remodeling and dysfunction with pressure overload. Cardiovasc Res 76 (2007) 303-310
48. Neschen S., Morino K., Rossbacker J.C., et al. Fish oil regulates adiponectin secretion by a peroxisome proliferator-activated receptor-gamma-dependent mechanism in mice. Diabetes 55 (2006) 924-928
49. Berg A.H., and Scherer P.E. Adipose tissue, inflammation, and cardiovascular disease. Circ Res 96 (2005) 939-949
50. Itoh M., Suganami T., Satoh N., et al. Increased adiponectin secretion by highly purified eicosapentaenoic acid in rodent models of obesity and human obese subjects. Arterioscler Thromb Vasc Biol 27 (2007) 1918-1925
51. Shibata R., Sato K., Pimentel D.R., et al. Adiponectin protects against myocardial ischemia-reperfusion injury through. Nat Med 11 (2005) 1096-1103
52. Ouchi N., and Walsh K. Adiponectin as an anti-inflammatory factor. Clin Chim Acta 380 (2007) 24-30
53. Mehra M.R., Lavie C.J., Ventura H.O., and Milani R.V. Fish oils produce anti-inflammatory effects and improved body weight in severe heart failure. J Heart Lung Transplant 25 (2006) 834-838
54. Fonarow G.C. Statins and n-3 fatty acid supplementation in heart failure. Lancet 372 (2008) 1195-1196
55. Bays H. Clinical overview of Omacor: a concentrated formulation of omega-3 polyunsaturated fatty acids. Am J Cardiol 98 (2006) 71i-76i
56. Bays H. Rationale for prescription omega-3-acid ethylester therapy for hypertriglyceridemia: a primer for clinicians. Drugs Today (Barc) 44 (2008) 205-246
57. Bays H., Tighe A.P., Sadovsky R., and Davidson M.H. Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications. Expert Rev Cardiovasc Ther 6 (2008) 391-409
58. Kris-Etherton P.M., Harris W.S., and Appel L.J. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 106 (2002) 2747-2757
59. Harris W.S. N-3 fatty acids and serum lipoproteins: human studies. Am J Clin Nutr 65 Suppl (1997) 1645S-1654S
60. Berger J., and Moller D.E. The mechanisms of action of PPARs. Annu Rev Med 53 (2002) 409-435
61. Huang B., Wu P., Bowker-Kinley M.M., and Harris R.A. Regulation of pyruvate dehydrogenase kinase expression by peroxisome proliferator-activated receptor-alpha ligands, glucocorticoids, and insulin. Diabetes 51 (2002) 276-283
62. Harris W.S., Ginsberg H.N., Arunakul N., et al. Safety and efficacy of Omacor in severe hypertriglyceridemia. J Cardiovasc Risk 4 (1997) 385-391
63. Davidson M.H., Stein E.A., Bayes H.E., et al., for the COMBination of prescription Omega-3 with Simvastatin (COMBOS) Investigators. Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/day to simvastatin 40 mg/day in hypertriglyceridemic patients: an 8-week randomized, double-blind, placebo-controlled study. Clin Ther 29 (2007) 1354-1367
64. Harris W.S., and Jacobson T.A. Omega-3 fatty acids. In: Ballantyne C.M. (Ed). Clinical Lipidology: A Companion to Braunwald's Heart Disease (2009), Saunders, an imprint of Elsevier Inc., Philadelphia, PA 326-338
65. Harris W.S. Omega-3 fatty acids and cardiovascular disease a case for omega-3 index as a new risk factor. Pharmacol Res 55 (2007) 217-223
66. Ventura H.O., Milani R.V., Lavie C.J., et al. Cycosporine-induced hypertension: efficacy of omega-3 fatty acids in patients after cardiac transplantation. Circulation 88 (1993) 11281-11285
67. Theis F., Garry J.M., Yaquoob P., et al. Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomized controlled trial. Lancet 3161 (2003) 477-485
68. Din J.N., Harding S.A., Valerio C.J., et al. Dietary intervention with oil rich fish reduces platelet-monocyte aggregation in man. Atherosclerosis 197 (2008) 290-296
69. Mozaffarian D., and Rimm E.B. Fish intake, contaminants, and human health: evaluating the risks and the benefits [errata in JAMA 2007;297:5091]. JAMA 296 (2006) 1885-1899
70. Madsen T., Schmidt E.B., and Christensen J.H. The effect of n-3 fatty acids on C-reactive protein levels in patients with chronic renal failure. J Ren Nutr 17 (2007) 258-263
71. Zhao G., Etherton T.D., Martin K.R., Gilles P.J., West S.G., and Kris-Etherton P.M. Dietary alpha-linolenic acid inhibits proinflammatory cytokine production by peripheral blood mononuclear cells in hypercholesterolemic subjects. Am J Clin Nutr 85 (2007) 385-391
72. Itoh M., Suganami T., Satoh N., et al. Increased adiponectin secretion by highly purified eicosapentaenoic acid in rodent models of obesity and human obese subjects. Arterioscler Thromb Vasc Biol 27 (2007) 1918-1925
73. Harris W.S., Gonzales M., Laney N., Sastre A., and Borkon A.M. Effects of omega-3 fatty acids on heart rate in cardiac transplant recipients. Am J Cardiol 98 (2006) 1393-1395
74. USDA Agricultural Research Service. Nutrient Data Laboratory. http://www.ars.usda.gov/nutrientdata Accessed January 23, 2008
75. Conquer J.A., and Holub B.J. Dietary docosahexaenoic acid as a source of eicosapentaenoic acid in vegetarians and omnivores. Lipids 32 (1997) 341-345
76. Park Y., and Harris W.S. Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance. J Lipid Res 44 (2003) 455-463
77. Albert C.M., Campos H., Stampfer M.J., et al. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 346 (2002) 1113-1118
78. Mori T.A., and Woodman R.J. The independent effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular risk factors in humans. Curr Opin Clin Nutr Metab Care 9 (2006) 95-104
79. Harris W.S. Expert opinion: omega-3 fatty acids and bleeding-cause for concern?. Am J Cardiol 99 (2007) 44C-46C
80. U.S. Food and Drug Administration, Department of Health and Human Services. Backgrounder for the 2004 FDA/EPA Consumer Advisory: What you Need to Know About Mercury in Fish and Shellfish. http://www.fda.gov/oc/opacom/hottopics/mercury/backgrounder.html Accessed January 24, 2008
81. Hibbeln J.R., Davis J.M., Steer C., et al. Maternal seafood consumption in pregnancy and neurodevelopmental outcomes in childhood. ALSPCA study: an observational cohort study. Lancet 369 (2007) 578-585
82. Mozaffarian D., and Rimm E.B. Fish intake, contaminants, and human health: evaluating the risks and the benefits [errata in JAMA 2007;297:5901]. JAMA 296 (2006) 1885-1899
83. Foran S.E., Flood J.G., and Lewandrowski K.B. Measurement of mercury levels in concentrated over-the-counter fish oil preparations: is fish oil healthier than fish?. Arch Pathol Lab Med 127 (2003) 1603-1605
84. Harris W.S., Kris-Etherton P.M., and Harris K.A. Intakes of long-chain omega-3 fatty acid associated with reduced risk for death from coronary heart disease in healthy adults. Curr Atheroscler Rep 10 (2008) 503-509
85. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP). JAMA 285 (2001) 2486-2497
86. World Health Organization. Diet, Nutrition, and the Prevention of Chronic Diseases: Report of a Joint WHO/FAO Expert Consultation. Technical report No. 916 (2003), World Health Organization, Geneva
87. DeBacker G., Ambrosioni E., Borch-Johnsen K., et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 24 (2003) 1601-1610
88. UK Scientific Advisory Committee on Nutrition. Advice on Fish Consumption Benefits and Risks (2004), The Stationery Office, London
89. Franz M.J., Bantle J.P., Beebe C.A., et al. Nutrition principles and recommendations in diabetes. Diabetes Care 27 Suppl 1 (2004) S36-S46
90. Harris W.S. The omega-3 index as a risk factor for coronary heart disease. Am J Clin Nutr 87 (2008) 1997S-2002S